HIV-1 subtypes and drug-resistance mutation sites in HIV/AIDS patients with antiretroviral-therapy failure

Journal Title: Shanghai Journal of Preventive Medicine - Year 2023, Vol 35, Issue 3

Abstract

ObjectiveTo analyze the characteristics of HIV-1 subtypes and drug-resistance mutation sites among HIV-infected patients who received high-efficiency antiretroviral therapy but failed.MethodsA total of 130 plasma samples were collected from the patients who received antiviral treatment for 6 months in Taizhou City of Zhejiang Province in 2021 but failed the treatment and the viral load was ≥1 000 copies·mL-1. Nucleic acid in the samples was extracted, and the pol gene was amplified by nested reverse transcription PCR. After next-generation sequencing, online tools were used to compare and analyze the subtypes and drug-resistant mutation sites.ResultsA total of 110 samples were successfully sequenced. The main HIV-1 subtype was CRF01_AE, accounting for 42.72% (47 cases), followed by CRF07_BC, 35.45% (39 cases); CRF08_BC, 10.00% (11 cases); CRF85_BC , 8.18% (9); and a small number of B subtype, 1.81% (2 cases) and C subtype, 1.81% (2 cases). The online tool comparison showed that there were 67 cases with mutations of drug-resistance sites and 61 cases with drug-resistance. The mutation sites were mainly M184V, K103N, K65R and V181C, and the mutation rates were 20.00% (22 cases), 10.91% (12 cases), 8.18% (9 cases) and 8.18% (9 cases), respectively. These mutation sites caused different degrees of resistance to nucleoside reverse transcriptase inhibitors (NRTI), non- nucleoside reverse transcriptase inhibitors (NNRTI) and protease inhibitors (PI), including 45 cases of NRTI, 61 cases of NNRTI and 2 cases of PI resistance.ConclusionThe HIV infected people who fail the treatment in Taizhou are mainly with the subtypes CRF01_AE and CRF07_BC. The rate of drug-resistance mutation is at a moderate level, mainly due to the mutation of NRTI and NNRTI drug-resistance sites, and a small number of PI drug-resistance sites. Therefore, the antiviral treatment plan for HIV infected people should be reasonably adjusted, and the detection of drug-resistance mutation sites should be strengthened to avoid the generation of transmissible drug-resistance strains.

Authors and Affiliations

LIN Junxiao,WANG Hongzhu,LI Congcong,SHENG Ying,LI Guixia,

Keywords

Related Articles

Effects of different feeding patterns on physical and nutritional status of infants aged 6‒12 months

ObjectiveTo analyze the effects of different feeding patterns on the physical and nutritional status of children aged 6‒12 months, so as to provide reference for promoting scientific feeding and health development of...

Analysis of influenza surveillance results in Jingzhou, Hubei Province from 2016 to 2021

ObjectiveTo understand the epidemiological characteristics of influenza in Jingzhou from 2016 to 2021, so as to provide scientific evidence for the formulation of influenza prevention and control policies in this regio...

Key issues in the response of tertiary public hospitals to public health emergencies in China

ObjectiveTo identify and clarify the key issues faced by tertiary hospitals in responding to public health emergencies.MethodsA literature review index system was constructed, and key issues were identified using hierarc...

Coffee intake and cancer: an umbrella review of meta-analyses

ObjectiveWith the increase in coffee consumption, its impact on health has garnered significant attention. However, the relationship between coffee intake and cancer risk remains controversial in epidemiological stud...

Analysis of late detection of HIV/AIDS cases aged 50 years and above in Jilin Province

ObjectiveTo investigate the late detection of HIV/AIDS cases in the elderly in Jilin Province and analyze its influencing factors, to provide theoretical basis for improving their life quality.MethodsThe first CD4 valu...

Download PDF file
  • EP ID EP742089
  • DOI -
  • Views 10
  • Downloads 0

How To Cite

LIN Junxiao, WANG Hongzhu, LI Congcong, SHENG Ying, LI Guixia, (2023). HIV-1 subtypes and drug-resistance mutation sites in HIV/AIDS patients with antiretroviral-therapy failure. Shanghai Journal of Preventive Medicine, 35(3), -. https://europub.co.uk/articles/-A-742089